Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 6, 2003

View Archived Issues

CP-690550 prevents organ transplant rejection in monkeys

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Schering AG claims novel inhibitors of carboxypeptidase B and their use in thrombotic disorders

New GluR5 antagonists and their use in pain and migraine

Novartis scientists identify new steryl-sulfatase inhibitors

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

Novartis patent covers new inhibitors of PKC and IL-2 production

GlaxoSmithKline researchers prepare and test a new CCR3 antagonist

New antibacterial tetracyclines synthesized by Paratek team

BMP2 gene and variants linked to osteoporosis

Nexium i.v. provides faster and more effective acid control than pantoprazole

Berna grants HBsAg rights to Dynavax

Merger agreement between aaiPharma and CIMA terminated; CIMA to merge with Cephalon

Phase II results for HE-2200 fail to confirm earlier findings of cholesterol reduction

Kos and Takeda to copromote Niaspan and Advicor in U.S.

Roll-out of Forsteo across E.U.

Encouraging interim results from Alzhemed extension study

Grant supports research into antiaminophospholipid antibodies for Lassa fever

Pevion advances first vaccine into clinical testing

Ark Therapeutics granted patent for EG-009

Repligen evaluates subcutaneous dosage form of secretin

New European approval for Bondronat

YM BioSciences cleared to begin pivotal trial of tesmilifene

T-2639, a novel PAI-1 inhibitor, presented at AIMECS 03

Promising new agent for urinary incontinence discovered by Kyorin

Potent and selective inhibitor of human mast cell tryptase identified at Mochida

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...